ARTICLE | Clinical News
ND0612H: Phase I started
June 22, 2015 7:00 AM UTC
NeuroDerm began an open-label, dose-finding, U.K. Phase I trial to compare single doses of subcutaneous ND0612H vs. Duopa carbidopa/levodopa intestinal gel in about 24 healthy volunteers. ...